Paul R. Sasso

Paul Sasso practices at St. John's Riverside Hospital in Yonkers, New York, part of St. John's Riverside Hospital.

Paul Sasso's NPI, 1962651505, was assigned on September 18, 2008. Paul Sasso graduated from State University of New York Downstate Medical Center College of Medicine in 2007. Paul Sasso holds New York license AN1865243-RI5.

Paul Sasso's primary practice is St. John's Riverside Hospital, at 976 North Broadway, Yonkers, NY 10701 in Westchester County. The practice phone is (914) 964-4444. Paul Sasso also practices at St Johns Riverside Hospital - Andrus Pavillion, 967 N Broadway, Yonkers, NY 10701.

Paul Sasso's primary practice is St. John's Riverside Hospital in Yonkers, New York, part of St. John's Riverside Hospital. The medical group on file is Symphony Medical. Dmand AI also links Paul Sasso to 1 more breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Paul Sasso practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Paul Sasso's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Paul Sasso is licensed in New York.

CMS data shows 180 Medicare services from Paul Sasso across 3 procedure codes in 2024, for 175 Medicare patients. Medicare paid $25,019 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 175 Medicare patients who saw Paul Sasso in 2024. The largest group is 75 to 84, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Paul Sasso's median patient age at 40, with 58% women.

In 2024, Paul Sasso wrote 40 Medicare Part D claims for 35 patients. 93% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $72 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Paul Sasso accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 18 general payments to Paul Sasso from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 99% of the total. Gilead Sciences, Inc. paid the most, $54,925.

Paul Sasso graduated from State University of New York Downstate Medical Center College of Medicine in 2007.